Home
About
Overview
Sharing Data
ORCID
Help
History (7)
Management of Sepsis and Septic Shock
Respiratory guidelines--which real world?
University of Chicago phase II consortium trial of selumetinib (MEKi) demonstrates low tolerability and efficacy in relapsed DLBCL.
Risk of Procedural Hemorrhage.
Phase II study of yttrium-90-ibritumomab tiuxetan in patients with relapsed or refractory mantle cell lymphoma.
See All 7 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Results (38)
More Search Options
Match
Type
Why
Lebeau, Michelle M.
Person
Why?
Etiology of Alkylator-Induced Myeloid Leukemia
Grant
Why?
Strauss, Bernard
Person
Why?
He, Chuan
Person
Why?
Olopade, Olufunmilayo
Person
Why?
Godley, Lucy
Person
Why?
Salgia, Ravi
Person
Why?
Cox, Nancy Jean
Person
Why?
Pritchard, Jonathan
Person
Why?
Nakamura, Yusuke
Person
Why?
Weichselbaum, Ralph R.
Person
Why?
Bell, Graeme
Person
Why?
Larson, Richard A.
Person
Why?
Stock, Wendy
Person
Why?
Mcnerney, Megan
Person
Why?
Per Page
15
25
50
100
Page
of 3
Next
Prev
Search Criteria
Molecular
analysis
genetic
pathways
leading
myeloid leukemias
Filter by Type
All
(38)
People
(37)
Research
(1)
_
Click "Why?" to see why an item matched the search.